Clinical Trial Update: Neurocysticercosis: Combined Treatment With Praziquantel (PZQ) and Albendazole (ABZ) [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports results from a combined treatment with praziquantel and albendazole for neurocysticercosis and related epilepsy across Phase …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Neurocysticercosis

Drugs mentioned

• Albendazole (ALBENDAZOLE)
• Praziquantel (Praziquantel)

Snippet

Sponsor: Universidad Peruana Cayetano Heredia | Conditions: Neurocysticercosis, Epilepsy | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2013-08-07